Cardiovascular and Renal Effectiveness of GLP-1 Receptor Agonists vs. Other Glucose-Lowering Drugs in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Real-World Studies

Cardiovascular outcome trials (CVOT) showed that treatment with glucagon-like peptide-1 receptor agonists (GLP-1RA) is associated with significant cardiovascular benefits. However, CVOT are scarcely representative of everyday clinical practice, and real-world studies could provide clinicians with mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Caruso, Irene, Cignarelli, Angelo, Sorice, Gian Pio, Natalicchio, Annalisa, Perrini, Sebastio, Laviola, Luigi, Giorgino, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879165/
https://www.ncbi.nlm.nih.gov/pubmed/35208256
http://dx.doi.org/10.3390/metabo12020183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879165/
https://www.ncbi.nlm.nih.gov/pubmed/35208256
http://dx.doi.org/10.3390/metabo12020183

Ejemplares similares